Seven recent, individually attributed price targets were reviewed. They are: JPMorgan at $65 (November 10, 2026, raised from $56), RBC Capital at $61 (October 5, 2026), TD Cowen at $61 (September 15, 2026), Morgan Stanley at $54 (October 16, 2026), Goldman Sachs at $54 (August 17, 2026), Scotiabank at $54 (August 14, 2026), and BMO Capital at $51 (September 17, 2026). I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The average of these seven targets is about $57.14, rounded to $57, with a range of $51 to $65. Every target reviewed carries a Buy or Overweight-equivalent rating, so the disagreement is not about direction but about magnitude. The gap between $51 and $65 reflects differing assumptions about how quickly Brookfield's unrealized carried interest converts into realized cash earnings and what multiple investors will pay for that earnings mix.
With shares near $41.70, a move to $57 implies roughly 37% upside — a substantial move that would require a sustained re-rating, not just a favorable quarter. The path would likely run through continued growth in fee-bearing capital, a successful "carry step-up" in 2027, and a higher multiple on distributable earnings (DE), the cash-based measure Brookfield emphasizes because GAAP earnings are volatile.
Third-quarter results showed DE per share of $0.73, up about 16% year over year, with DE before realizations up 14% to $0.64. Fee-bearing capital reached $682 billion, up 13%, and the company raised $25 billion in the quarter and $123 billion year to date. Wealth Solutions posted record DE of $511 million, up 22%.
Several verified factors support the bull case. Management pointed to a "meaningful step-up" in carried interest in 2027, led by infrastructure and energy, as funds pass their preferred-return hurdles. Accumulated unrealized carry climbed to $13.0 billion. The sixth flagship infrastructure fund added $13 billion in commitments after quarter-end to reach $26 billion. Nearly $900 million of buybacks year to date signals that management sees value at current prices. From what I see, the corporate simplification expected to close in early December 2026, with Class A shares trading under the BN symbol on both the NYSE and TSX, could also help clarify the story for investors.
Improving net investment yield in Wealth Solutions, driven partly by rotation into Treasuries, also supports the earnings trajectory.
The principal risks are equally concrete. Quarterly fundraising slowed to $25 billion from a record $77 billion in the second quarter, and fee-bearing capital growth eased to 13% from 19%. Annuity originations in Wealth Solutions declined, and management indicated it is prioritizing profitability over volume. GAAP results remain noisy, and the stock trades at a high price-to-earnings multiple on reported earnings, making it sensitive to sentiment.
Carried interest depends on asset-sale markets, which are vulnerable to interest-rate and geopolitical conditions. Management also flagged uncertainty around access to alternatives in U.S. retirement plans, a potential long-term demand driver that could be delayed.
Brookfield shares trade within a 52-week range of roughly $35.61 to $49.57, putting the stock well below its prior high but above its low. The $49–$50 zone marks a meaningful resistance area near the 52-week peak, while the $35–$36 area represents the lower support band. A sustained move toward $57 would require first clearing the $49–$50 range and then establishing new highs — a structure that, on a technical basis, is a multi-stage advance rather than a single leg.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms do not always state it explicitly, and the wide $51–$65 range shows that timing assumptions differ. Investors should watch quarterly DE and fee-bearing capital trends, the pace of carried-interest realization, the completion of the December corporate simplification, and any regulatory developments on private-market access in retirement accounts. Changes to analyst targets, particularly revisions tied to the 2027 carry outlook, will also matter. I’m watching this closely as the earnings trajectory unfolds.
In my view, Tickeron's AI Daily Buy/Sell Signals provide a practical way to track BN and similar names with data-driven updates. The platform continuously monitors thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. It helps complement manual research by highlighting shifting trends more efficiently.
The $57 target is the arithmetic mean of seven verified analyst price targets ranging from $51 to $65, representing about 37% upside from roughly $41.70. The case for the move rests on growing fee-bearing capital, record Wealth Solutions earnings, and a meaningful 2027 carried-interest step-up, supported by buybacks and a December corporate simplification. The obstacles are a broad slowdown in fundraising and annuity originations, volatile GAAP earnings, and dependence on asset-sale markets for realized carry. Whether the shares reach $57 depends on converting these tailwinds into sustained cash earnings and a higher multiple — an outcome that remains uncertain and is not a forecast.
One tool I rely on for research is Tickeron’s suite of AI platforms, which help scan opportunities and generate signals across a wide range of assets. The AI Daily Buy/Sell Signals feature stands out for its ability to deliver timely, automated insights that align with my own review of fundamentals and technicals. It serves as a useful complement when evaluating names like BN alongside broader market trends.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BN advanced for three days, in 225 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on BN as a result. In 52 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
BN moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BN crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
The Aroon Indicator entered an Uptrend today. In 145 of 270 cases where BN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
The 10-day RSI Indicator for BN moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 28 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 56 cases where BN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
BN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 47 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. BN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.174) is normal, around the industry mean (2.423). BN has a moderately high P/E Ratio (73.893) as compared to the industry average of (8.341). Projected Growth (PEG Ratio) (0.110) is also within normal values, averaging (1.318). Dividend Yield (0.007) settles around the average of (0.274) among similar stocks. P/S Ratio (1.135) is also within normal values, averaging (15.906).
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an alternative asset manager which owns, manages and operates real estate, financial and power generation related businesses
Industry InvestmentManagers